share_log

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

4：持股变动声明-董事 Lewis-Hall Freda C
美股SEC公告 ·  2024/11/21 05:33

Moomoo AI 已提取核心信息

Freda C. Lewis-Hall, reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US). On November 18, 2024, Lewis-Hall purchased 437,976 shares of common stock at a price of $0.0919 per share. Following this transaction, she directly holds a total of 437,976 shares. Additionally, she has an indirect beneficial ownership of 2,520,311 shares in the company, as detailed in the transaction report. The transaction has been marked as completed.
Freda C. Lewis-Hall, reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US). On November 18, 2024, Lewis-Hall purchased 437,976 shares of common stock at a price of $0.0919 per share. Following this transaction, she directly holds a total of 437,976 shares. Additionally, she has an indirect beneficial ownership of 2,520,311 shares in the company, as detailed in the transaction report. The transaction has been marked as completed.
Freda C. Lewis-Hall报告在Conduit Pharmaceuticals（CDt.US）公司股份方面有重大收购。2024年11月18日，Lewis-Hall以0.0919美元每股的价格购入437,976股普通股。在这项交易之后，她直接持有437,976股。此外，根据交易报告的详细信息，她在该公司拥有2520311股的间接受益所有权。该交易已被标记为已完成。
Freda C. Lewis-Hall报告在Conduit Pharmaceuticals（CDt.US）公司股份方面有重大收购。2024年11月18日，Lewis-Hall以0.0919美元每股的价格购入437,976股普通股。在这项交易之后，她直接持有437,976股。此外，根据交易报告的详细信息，她在该公司拥有2520311股的间接受益所有权。该交易已被标记为已完成。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间